Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention

被引：0
|
作者：
Lutz E Kraushaar
Alexander Krämer
机构：
[1] University of Bielefeld,Department of Public Health Medicine
来源：
BMC Public Health | / 9卷
关键词：
Cardiometabolic Disease; Metabolically Healthy Obese; Population Strategy; Reduce Disease Incidence; Attributable Proportion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings?-- Comment on "Intralesional Methotrexate for Keratoacanthomas: A Case Series"
    Sanza, P. Lopez
    Fernandez-Parrado, M.
    Travesedo, E. Escario
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (03): : T328 - T329
  • [42] IMPLICATIONS OF THE PRIMARY PREVENTION TRIALS AGAINST CORONARY HEART-DISEASE
    KANNEL, WB
    [J]. JOURNAL OF HYPERTENSION, 1990, 8 : S245 - S250
  • [43] Primary and secondary prevention of coronary heart disease:: What can we afford?
    Kübler, W
    Kreuzer, J
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1999, 88 (02): : 85 - 89
  • [44] Aspirin for primary cardiovascular disease prevention: what we know and what we don't know
    Song, Ning
    French, John K.
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (01) : 12 - 14
  • [45] A paradigm shift in the scope of practice for health psychologists: Training health psychologists to be primary care case managers
    James, LC
    Folen, FA
    [J]. PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 1999, 30 (04) : 352 - 356
  • [46] Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care
    Stol, Daphne M.
    Over, Eelco A. B.
    Badenbroek, Ilse F.
    Hollander, Monika
    Nielen, Mark M. J.
    Kraaijenhagen, Roderik A.
    Schellevis, Francois G.
    de Wit, Niek J.
    de Wit, G. Ardine
    [J]. BMC MEDICINE, 2021, 19 (01)
  • [47] Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care
    Daphne M. Stol
    Eelco A. B. Over
    Ilse F. Badenbroek
    Monika Hollander
    Mark M. J. Nielen
    Roderik A. Kraaijenhagen
    François G. Schellevis
    Niek J. de Wit
    G. Ardine de Wit
    [J]. BMC Medicine, 19
  • [48] Primary prevention of coronary heart disease -: Where do we go from here?
    Gotto, AM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (07) : 922 - 924
  • [49] Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?
    Leening, Maarten J. G.
    Cook, Nancy R.
    Ridker, Paul M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (20) : 1542 - 1547
  • [50] Low-dose aspirin therapy for primary prevention of cardiovascular disease: where are we at?
    Pugliese, Nicola Riccardo
    Taddei, Stefano
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (12) : 1170 - 1171
12345